AstraZeneca Shares Soar 7% as Pharma Giant Unveils Breakthrough Cancer Drug Data
Anglo-Swedish pharmaceutical giant AstraZeneca has made investors jump with record-breaking trial outcomes of its next-generation lung cancer treatment, and its shares shot up by 7% on the London Stock Exchange. The influx, in a booming health industry, …